ipamorelin mod grf 129 mix Fragment, Modified GRF, Blend – Nordsci CJC-1295 Peptide Therapy: Benefits &

Synthetic analogue of insulin-like growth factor 1 (IGF-1) studied in cellular growth and signalling research Engineered with an extended amino acid sequence and reduced binding affinity to IGF binding proteins compared to native IGF-1 Investigated in laboratory models involving cell proliferation, differentiation, and metabolic signalling pathways Supplied as high purity lyophilised peptide powder Form: Lyophilised peptide powder Strength: 1mg Purity: 99% Verification: HPLC and Mass Spectrometry

Sleep is typically the first benefit patients notice

Both peptides may be used under medical supervision when prescribed and monitored appropriately

Czechia Dual peptide blend with verified analytical composition Assay content: Ipamorelin 10.26 mg and CJC-1295 11.19 mg Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination High-purity growth hormone research peptide blend For research use only not for human or veterinary use For laboratory research only

Ipamorelin does not fit any of these categories